EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Anti-Hepatocellular Carcinoma Effects of Phillygenin: Integrated Network Pharmacology, Molecular Modeling, and Experimental Validation

Linhui Chen, Jiabin Huang, Dan Wang, Yanqiu Wu, Linbo Shi

Drug Design, Development and Therapy · 2026-11 · Volume 20 · 1-23

DOI: 10.2147/dddt.s627438 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Design, Development and Therapy, 2026-11. Verfasst von Linhui Chen und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, The Central Hospital of Yongzhou, Yongzhou, People's Republic of China. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Antineoplastic Agents, Phytogenic, Lignans. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsAntineoplastic Agents, PhytogenicLignansHumansNetwork PharmacologyCell ProliferationMolecular Docking SimulationAnimalsApoptosisMiceMolecular Dynamics SimulationDrug Screening Assays, AntitumorDose-Response Relationship, DrugMolecular StructureCell Movement

Stichwörter der Autor:innen

Phillygeninhepatocellular carcinomamolecular dockingmolecular dynamics simulationsnetwork pharmacology

Substanzen

phillygeninAntineoplastic Agents, PhytogenicLignans

Autor:innen und Institutionen

  • Department of Radiology, The Central Hospital of Yongzhou, Yongzhou, People's Republic of China.
  • Department of Radiology, Yongzhou Hospital Affiliated to University of South China, Yongzhou, People's Republic of China.

Zitieren

APA

Chen, L., Huang, J., Wang, D., Wu, Y., & Shi, L. (2026). Anti-Hepatocellular Carcinoma Effects of Phillygenin: Integrated Network Pharmacology, Molecular Modeling, and Experimental Validation. Drug Design, Development and Therapy, Volume 20, 1-23. https://doi.org/10.2147/dddt.s627438

Vancouver

Chen L, Huang J, Wang D, Wu Y, Shi L. Anti-Hepatocellular Carcinoma Effects of Phillygenin: Integrated Network Pharmacology, Molecular Modeling, and Experimental Validation. Drug Design, Development and Therapy. 2026;Volume 20:1-23. doi:10.2147/dddt.s627438

BibTeX
@article{Chen2026,
  author = {Chen, Linhui and Huang, Jiabin and Wang, Dan and Wu, Yanqiu and Shi, Linbo},
  title = {Anti-Hepatocellular Carcinoma Effects of Phillygenin: Integrated Network Pharmacology, Molecular Modeling, and Experimental Validation},
  journal = {Drug Design, Development and Therapy},
  year = {2026},
  volume = {Volume 20},
  pages = {1--23},
  doi = {10.2147/dddt.s627438}
}
Kostenlos starten →